about
Inhibiting Immune Checkpoints for the Treatment of Bladder CancerTargeted Therapies in Breast Cancer: New Approaches and Old ChallengesIdentification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCRPotential role of immunotherapy in advanced non-small-cell lung cancerBreast cancer and immunology: biomarker and therapeutic developments.Immune effect and safety evaluation of vaccine prepared by dendritic cells modified by rAAV-carrying BCSG1 gene.Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.Editorial: Prostate Cancer: What We Know and What We Would Like to Know.Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer.Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer.T-Cell Epitope Discovery for Therapeutic Cancer Vaccines.Disappearance of bone metastases in chemotherapy-resistant gastric cancer treated with antigen peptide-pulsed dendritic cell-activated cytotoxic T lymphocyte immunotherapy: A case report.Immunooncology in Breast Cancer: Active and Passive Vaccination StrategiesImmunomodulation Mediated by Anti-angiogenic Therapy Improves CD8 T Cell Immunity Against Experimental Glioma
P2860
Q26744758-7B2463D2-B7B4-443D-9F97-1BA48CCD12EBQ36058363-7848A1E1-5E7E-42FB-A157-5CFA235A35CAQ37126629-53E5FAE3-97F2-4BBF-8E34-D73F8C254EACQ37527869-AB84B44D-3B05-4ECF-A802-B000091130BCQ38584383-E385716B-3790-4547-82BB-3238DDE35108Q38750395-258238AB-AB23-48C7-9004-380AF4B2F86BQ38788212-DFF70779-1649-47EF-A1D3-6AC4D4DB7ECDQ40955296-EEDF4586-D222-4A7B-8F74-21961F182AC9Q42501422-B2AB39CF-9AFC-4172-B91F-BCB59943F49AQ47105585-674795E8-DF99-4DBC-BDE3-977078345897Q50145104-2E2FB093-8152-4AA8-8627-310AE88F4178Q50861629-5370FE52-E0CC-46F7-8568-FED1C8A04DC0Q55404516-C3E75B15-B79E-4E2A-B8BD-ADCC3D98A760Q57114269-F09E7D17-272E-4E1B-83FA-9ACE353CE274Q58733930-1163D866-84A2-4B21-8A1E-7A10B88AF0C1
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Immunotherapy for the treatment of breast cancer.
@en
type
label
Immunotherapy for the treatment of breast cancer.
@en
prefLabel
Immunotherapy for the treatment of breast cancer.
@en
P2860
P1476
Immunotherapy for the treatment of breast cancer.
@en
P2093
Brenda Ernst
Karen S Anderson
P2860
P2888
P356
10.1007/S11912-014-0426-9
P577
2015-02-01T00:00:00Z
P6179
1047402059